ATC

ATC-Index C07FB25

You are here: Startseite > ATC > C > C07 > C07F > C07FB

- ATC
Anatomisch-therapeutisch-chemische-Klassifikation mit Tagesdosen (ATC)
- C
KARDIOVASKULÄRES SYSTEM
- C07
BETA-ADRENOZEPTOR-ANTAGONISTEN
- C07F
BETA-ADRENOZEPTOR-ANTAGONISTEN UND ANDERE ANTIHYPERTENSIVA
- C07FB
Beta-Adrenozeptor-Antagonisten, selektiv, und andere Antihypertensiva

C07FB25

Atenolol, Chlortalidon und Hydralazin

ATC Code C07FB25 für Atenolol, Chlortalidon und Hydralazin

DDD info: Standarddosis: 1 Applikationsform O
ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us